共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R025115-25mg | 25mg | 5~7个工作日 |
N4-(4-苯氧基苯乙基)喹唑啉-4,6-二胺 QNZ (EVP4593) |
98% |
|
|
罗恩 | R025115-5mg | 5mg | 5~7个工作日 |
N4-(4-苯氧基苯乙基)喹唑啉-4,6-二胺 QNZ (EVP4593) |
98% |
|
|
罗恩 | R025115-100mg | 100mg | 5~7个工作日 |
N4-(4-苯氧基苯乙基)喹唑啉-4,6-二胺 QNZ (EVP4593) |
98% |
|
|
阿拉丁 | Q125550-5mg | 5mg | 现货 |
QNZ (EVP4593),NF-kB抑制剂 QNZ (EVP4593) |
Moligand™, ≥98% |
|
|
阿拉丁 | Q125550-25mg | 25mg | 现货 |
QNZ (EVP4593),NF-kB抑制剂 QNZ (EVP4593) |
Moligand™, ≥98% |
|
|
阿拉丁 | Q125550-100mg | 100mg | 现货 |
QNZ (EVP4593),NF-kB抑制剂 QNZ (EVP4593) |
Moligand™, ≥98% |
|
|
阿拉丁 | Q125550-10mg | 10mg | 现货 |
QNZ (EVP4593),NF-kB抑制剂 QNZ (EVP4593) |
Moligand™, ≥98% |
|
|
阿拉丁 | Q125550-50mg | 50mg | 现货 |
QNZ (EVP4593),NF-kB抑制剂 QNZ (EVP4593) |
Moligand™, ≥98% |
|
|
阿拉丁 | Q125550-250mg | 250mg | 现货 |
QNZ (EVP4593),NF-kB抑制剂 QNZ (EVP4593) |
Moligand™, ≥98% |
|
|
阿拉丁 | Q408542-1ml | 1ml | 现货 |
QNZ (EVP4593) QNZ (EVP4593) |
Moligand™, 10mM in DMSO |
|
|
阿拉丁 | Q125550-1mg | 1mg | 期货,请咨询 |
QNZ (EVP4593),NF-kB抑制剂 QNZ (EVP4593) |
Moligand™, ≥98% |
|
|
凯为 | JZ00DARP-50mg | 50mg | 期货,请咨询 |
N4-[2-(4-苯氧基苯基)乙基]-4,6-喹唑啉二胺 6-Amino-4-(4-phenoxyphenylet... |
99% |
|
|
凯为 | JZ00DARP-100mg | 100mg | 期货,请咨询 |
N4-[2-(4-苯氧基苯基)乙基]-4,6-喹唑啉二胺 6-Amino-4-(4-phenoxyphenylet... |
99% |
|
|
凯为 | JZ00DARP-250mg | 250mg | 期货,请咨询 |
N4-[2-(4-苯氧基苯基)乙基]-4,6-喹唑啉二胺 6-Amino-4-(4-phenoxyphenylet... |
99% |
|
|
凯为 | JZ00DARP-5mg | 5mg | 期货,请咨询 |
N4-[2-(4-苯氧基苯基)乙基]-4,6-喹唑啉二胺 6-Amino-4-(4-phenoxyphenylet... |
99% |
|
|
凯为 | JZ00DARP-10mg | 10mg | 期货,请咨询 |
N4-[2-(4-苯氧基苯基)乙基]-4,6-喹唑啉二胺 6-Amino-4-(4-phenoxyphenylet... |
99% |
|
|
毕得 | BD159842-5mg | 5mg | 现货 |
N4-(4-苯氧基苯乙基)喹唑啉-4,6-二胺 N4-(4-Phenoxyphenethyl)quina... |
99% |
|
|
毕得 | BD159842-10mg | 10mg | 现货 |
N4-(4-苯氧基苯乙基)喹唑啉-4,6-二胺 N4-(4-Phenoxyphenethyl)quina... |
99% |
|
|
毕得 | BD159842-50mg | 50mg | 现货 |
N4-(4-苯氧基苯乙基)喹唑啉-4,6-二胺 N4-(4-Phenoxyphenethyl)quina... |
99% |
|
|
毕得 | BD159842-100mg | 100mg | 现货 |
N4-(4-苯氧基苯乙基)喹唑啉-4,6-二胺 N4-(4-Phenoxyphenethyl)quina... |
99% |
|
|
毕得 | BD159842-250mg | 250mg | 现货 |
N4-(4-苯氧基苯乙基)喹唑啉-4,6-二胺 N4-(4-Phenoxyphenethyl)quina... |
99% |
|
|
梯希爱 | Q0109-5MG | 5MG | 现货 |
QNZ QNZ |
98.0% |
|
|
梯希爱 | Q0109-25MG | 25MG | 现货 |
QNZ QNZ |
98.0% |
|
|
百灵威 | JK977565-5MG | 5MG | 1天 |
N4-(4-苯氧基苯乙基)喹唑啉-4,6-二胺 QNZ, 98%, shows strong inhib... |
98% |
|
|
TRC | A621350-10mg | 10mg | 期货,请咨询 |
N4-[2-(4-苯氧基苯基)乙基]-4,6-喹唑啉二胺 6-Amino-4-(4-phenoxyphenylet... |
|
|
|
Sigma | SML0579-5MG | 5mg | 请咨询 |
EVP4593 EVP4593 |
≥98% (hplc)≥98% (HPLC) | 咨询 | 请联系客服购买! |
Sigma | SML0579-25MG | 25mg | 请咨询 |
EVP4593 EVP4593 |
≥98% (hplc)≥98% (HPLC) | 咨询 | 请联系客服购买! |
源叶 | S80792-5mg | 5mg | 现货 |
QNZ (EVP4593) QNZ (EVP4593) |
99% |
|
|
源叶 | S80792-10mg | 10mg | 现货 |
QNZ (EVP4593) QNZ (EVP4593) |
99% |
|
|
源叶 | S80792-25mg | 25mg | 期货,请咨询 |
QNZ (EVP4593) QNZ (EVP4593) |
99% |
|
|
源叶 | S80792-100mg | 100mg | 期货,请咨询 |
QNZ (EVP4593) QNZ (EVP4593) |
99% |
|
|
源叶 | T98606-1ml | 1ml | 期货,请咨询 |
QNZ (EVP4593) QNZ (EVP4593) |
10mM in DMSO |
|
|
Target Mol | T6204-1mg | 1mg | 现货 |
化合物 QNZ QNZ |
99.17% |
|
|
Target Mol | T6204-2mg | 2mg | 现货 |
化合物 QNZ QNZ |
99.17% |
|
|
Target Mol | T6204-5mg | 5mg | 现货 |
化合物 QNZ QNZ |
99.17% |
|
|
Target Mol | T6204-10mg | 10mg | 现货 |
化合物 QNZ QNZ |
99.17% |
|
|
Target Mol | T6204-25mg | 25mg | 现货 |
化合物 QNZ QNZ |
99.17% |
|
|
Target Mol | T6204-50mg | 50mg | 现货 |
化合物 QNZ QNZ |
99.17% |
|
|
Target Mol | T6204-100mg | 100mg | 现货 |
化合物 QNZ QNZ |
99.17% |
|
|
Target Mol | T6204-1mL | 1mL | 现货 |
化合物 QNZ QNZ |
99.17% |
|
|
Am | A230954-1mg | 1mg | 现货 |
QNZ QNZ |
98% |
|
|
Am | A230954-5mg | 5mg | 现货 |
QNZ QNZ |
98% |
|
|
Am | A230954-50mg | 50mg | 现货 |
QNZ QNZ |
98% |
|
|
Am | A230954-10mg | 10mg | 现货 |
QNZ QNZ |
98% |
|
|
MCE | HY-13812-50mg | 50mg | 现货 |
QNZ QNZ |
99.51% |
|
|
MCE | HY-13812-10mg | 10mg | 现货 |
QNZ QNZ |
99.51% |
|
|
MCE | HY-13812-10mM*1mL | 10mM*1mL | 现货 |
QNZ QNZ |
99.51% |
|
|
MCE | HY-13812-5mg | 5mg | 现货 |
QNZ QNZ |
99.51% |
|
|
MCE | HY-13812-1mg | 1mg | 现货 |
QNZ QNZ |
99.51% |
|
|